DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC – NeuBase Therapeutics, Inc. Transaction History
DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC portfolio value:
$395,000
portfolio value
DECHENG CAPITAL MANAGEMENT III (CAYMAN), LLC quarter portfolio value change:
-62.38%
quarter
NeuBase Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -655K | $0.4 | 1M | |
| Q2 2022 | share | 0.00% | 0 shares | -830K | $1.05 | 1M | |
| Q1 2022 | share | Increase | 0.00% | 1M shares | 1.88M | $1.88 | 1M |